250 related articles for article (PubMed ID: 11728950)
1. Steroid therapy and urinary transforming growth factor-beta1 in IgA nephropathy.
Haramaki R; Tamaki K; Fujisawa M; Ikedo H; Haramaki N; Okuda S
Am J Kidney Dis; 2001 Dec; 38(6):1191-8. PubMed ID: 11728950
[TBL] [Abstract][Full Text] [Related]
2. The effects of dual blockade of the renin-angiotensin system on urinary protein and transforming growth factor-beta excretion in 2 groups of patients with IgA and diabetic nephropathy.
Song JH; Lee SW; Suh JH; Kim ES; Hong SB; Kim KA; Kim MJ
Clin Nephrol; 2003 Nov; 60(5):318-26. PubMed ID: 14640237
[TBL] [Abstract][Full Text] [Related]
3. Effect of losartan and amlodipine on proteinuria and transforming growth factor-beta1 in patients with IgA nephropathy.
Park HC; Xu ZG; Choi S; Goo YS; Kang SW; Choi KH; Ha SK; Lee HY; Han DS
Nephrol Dial Transplant; 2003 Jun; 18(6):1115-21. PubMed ID: 12748343
[TBL] [Abstract][Full Text] [Related]
4. Urinary transforming growth factor-beta 1 in various types of nephropathy.
De Muro P; Faedda R; Fresu P; Masala A; Cigni A; Concas G; Mela MG; Satta A; Carcassi A; Sanna GM; Cherchi GM
Pharmacol Res; 2004 Mar; 49(3):293-8. PubMed ID: 14726227
[TBL] [Abstract][Full Text] [Related]
5. Value of urinary levels of interleukin-6, epidermal growth factor, monocyte chemoattractant protein type1 and transforming growth factor β1 in predicting the extent of fibrosis lesions in kidney biopsies of patients with IgA nephropathy.
Segarra-Medrano A; Carnicer-Caceres C; Valtierra-Carmeno N; Agraz-Pamplona I; Ramos-Terrades N; Jatem Escalante E; Ostos-Roldan E
Nefrologia; 2017; 37(5):531-538. PubMed ID: 28946966
[TBL] [Abstract][Full Text] [Related]
6. ACE inhibitors attenuate expression of renal transforming growth factor-beta1 in humans.
Shin GT; Kim SJ; Ma KA; Kim HS; Kim D
Am J Kidney Dis; 2000 Nov; 36(5):894-902. PubMed ID: 11054345
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-beta(1) in the kidney and urine of patients with glomerular disease and proteinuria.
Goumenos DS; Tsakas S; El Nahas AM; Alexandri S; Oldroyd S; Kalliakmani P; Vlachojannis JG
Nephrol Dial Transplant; 2002 Dec; 17(12):2145-52. PubMed ID: 12454225
[TBL] [Abstract][Full Text] [Related]
8. Urinary Transforming Growth Factor-beta 1 as a marker of response to immunosuppressive treatment, in patients with crescentic nephritis.
Goumenos DS; Kalliakmani P; Tsakas S; Sotsiou F; Vlachojannis JG
BMC Nephrol; 2005 Dec; 6():16. PubMed ID: 16367998
[TBL] [Abstract][Full Text] [Related]
9. Urinary interleukin-6 (IL-6) and transforming growth factor (TGF-β) levels in corticosteroidtreated patients with IgA nephropathy.
Kalliakmani P; Nakopoulou L; Tsakas S; Gerolymos M; Papasotiriou M; Goumenos DS
Clin Nephrol; 2011 Aug; 76(2):144-50. PubMed ID: 21762647
[TBL] [Abstract][Full Text] [Related]
10. Roles of TGF-beta1 and apoptosis in the progression of glomerulosclerosis in human IgA nephropathy.
Chihara Y; Ono H; Ishimitsu T; Ono Y; Ishikawa K; Rakugi H; Ogihara T; Matsuoka H
Clin Nephrol; 2006 Jun; 65(6):385-92. PubMed ID: 16792132
[TBL] [Abstract][Full Text] [Related]
11. Effect of IgA aggregates on transforming growth factor-beta1 production in human mesangial cells and the intraglomerular expression of transforming growth factor-beta1 in patients with IgA nephropathy.
Han SY; Ihm CG; Cha DR; Kang YS; Han KH; Kim HK; Han JY
Korean J Intern Med; 2005 Mar; 20(1):40-7. PubMed ID: 15906952
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of Modified Huangqi Chifeng decoction in alleviating renal fibrosis in rats with IgA nephropathy by inhibiting the TGF-β1/Smad3 signaling pathway through exosome regulation.
Zhao M; Yang B; Li L; Si Y; Chang M; Ma S; Li R; Wang Y; Zhang Y
J Ethnopharmacol; 2022 Mar; 285():114795. PubMed ID: 34737009
[TBL] [Abstract][Full Text] [Related]
13. Localization of transforming growth factors beta1 and beta2 and epidermal growth factor in IgA nephropathy.
Taniguchi Y; Yorioka N; Masaki T; Asakimori Y; Yamashita K; Yamakido M
Scand J Urol Nephrol; 1999 Aug; 33(4):243-7. PubMed ID: 10515087
[TBL] [Abstract][Full Text] [Related]
14. Precocious activation of genes of the renin-angiotensin system and the fibrogenic cascade in IgA glomerulonephritis.
Del Prete D; Gambaro G; Lupo A; Anglani F; Brezzi B; Magistroni R; Graziotto R; Furci L; Modena F; Bernich P; Albertazzi A; D'Angelo A; Maschio G
Kidney Int; 2003 Jul; 64(1):149-59. PubMed ID: 12787405
[TBL] [Abstract][Full Text] [Related]
15. [Urine excretion of a monocytic chemotaxic protein-1 and a transforming growth factor beta1 as an indicator of chronic glomerulonephritis progression].
Bobkova IN; Chebotareva NV; Kozlovskaia LV; Varshavskiĭ VA; Golitsyna EP
Ter Arkh; 2006; 78(5):9-14. PubMed ID: 16889042
[TBL] [Abstract][Full Text] [Related]
16. Urinary transforming growth factor-beta 1 in membranous glomerulonephritis.
Honkanen E; Teppo AM; Törnroth T; Groop PH; Grönhagen-Riska C
Nephrol Dial Transplant; 1997 Dec; 12(12):2562-8. PubMed ID: 9430852
[TBL] [Abstract][Full Text] [Related]
17. Glomerular transforming growth factor-beta1 mRNA as a marker of glomerulosclerosis-application in renal biopsies.
Yang CW; Hsueh S; Wu MS; Lai PC; Huang JY; Wu CH; Hu SA; Chen JF; Huang CC
Nephron; 1997; 77(3):290-7. PubMed ID: 9375822
[TBL] [Abstract][Full Text] [Related]
18. Urinary transforming growth factor-beta1 excretion in renal allograft recipients during the early post-transplantation period.
Goumenos DS; Tsakas S; Karavias D; Savidaki I; Karatzas T; Vlachojannis JG
Ren Fail; 2003 Jul; 25(4):561-8. PubMed ID: 12911160
[TBL] [Abstract][Full Text] [Related]
19. Serum miR-192 Is Related to Tubulointerstitial Lesion and Short-Term Disease Progression in IgA Nephropathy.
Fan Q; Lu R; Zhu M; Yan Y; Guo X; Qian Y; Zhang L; Dai H; Ni Z; Gu L
Nephron; 2019; 142(3):195-207. PubMed ID: 30808829
[TBL] [Abstract][Full Text] [Related]
20. Urinary transforming growth factor-beta in patients with glomerular diseases.
Murakami K; Takemura T; Hino S; Yoshioka K
Pediatr Nephrol; 1997 Jun; 11(3):334-6. PubMed ID: 9203185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
